Steven J. Rice
Net Worth
Last updated:
What is Steven J. Rice net worth?
The estimated net worth of Mr. Steven J. Rice is at least $4,109,736 as of 1 Jun 2023. He owns shares worth $464,754 as insider, has earned $850,502 from insider trading and has received compensation worth at least $2,794,480 in Vir Biotechnology, Inc..
What is the salary of Steven J. Rice?
Mr. Steven J. Rice salary is $698,620 per year as Chief Admin. Officer in Vir Biotechnology, Inc..
How old is Steven J. Rice?
Mr. Steven J. Rice is 65 years old, born in 1960.
What stocks does Steven J. Rice currently own?
As insider, Mr. Steven J. Rice owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Vir Biotechnology, Inc. (VIR) | Chief Admin. Officer | 106,840 | $4.35 | $464,754 |
What does Vir Biotechnology, Inc. do?
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; and VIR-1111 for the prevention of human immunodeficiency virus. The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited and Brii Biosciences Offshore Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with The Rockefeller University and MedImmune, Inc.; collaboration with WuXi Biologics and Glaxo Wellcome UK Ltd.; and a collaborative research agreement with GlaxoSmithKline Biologicals SA. It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. for the manufacture of SARS-COV-2 antibodies; and clinical collaboration with Gilead Sciences, Inc. for chronic hepatitis B virus. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.
Steven J. Rice insider trading
Vir Biotechnology, Inc.
Mr. Steven J. Rice has made 7 insider trades between 2021-2023, according to the Form 4 filled with the SEC. Most recently he sold 2,500 units of VIR stock worth $64,175 on 1 Jun 2023.
The largest trade he's ever made was exercising 10,000 units of VIR stock on 23 Aug 2021. As of 1 Jun 2023 he still owns at least 106,840 units of VIR stock.
Vir Biotechnology key executives
Vir Biotechnology, Inc. executives and other stock owners filed with the SEC:
- Dr. George A. Scangos (77) Pres, Chief Executive Officer & Director
- Dr. Herbert W. Virgin IV (69) Executive Vice President of Research & Chief Scientific Officer
- Mr. Howard Horn (47) Chief Financial Officer & Sec.
- Mr. Steven J. Rice (65) Chief Admin. Officer